Bennett Van Houten, PhD, co-director of the Genome Stability Program at UPMC Hillman Cancer Center, and Richard M. Cyert Professor of Molecular Oncology and professor of pharmacology and chemical biology in the University of Pittsburgh School of Medicine, is among…
Norman Wolmark, MD, received the Medallion for the Advancement of Surgical Care from the American Surgical Association this month. The American Surgical Association is our nation’s oldest and most prestigious surgical association. Dr. Wolmark has contributed to some of the…
Please join us in welcoming Marija Balic, MD, ScD, MBA to UPMC Hillman Cancer Center, effective March 1, 2024 as professor in the Department of Medicine, Division of Hematology/Oncology at the University of Pittsburgh. Dr. Balic will provide three half days…
Researchers from UPMC Hillman Cancer Center and colleagues published their results from the CAMILLA trial showing that combining cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer is a promising treatment, potentially expanding treatment options for patients with microsatellite stable…
Please join UPMC Hillman Cancer Center in welcoming Saad Sheikh, MD, effective February 1, 2024. Dr. Sheikh is an assistant professor in the Department of Radiation Oncology at the University of Pittsburgh and a member of the Genome Stability Program…
Please join UPMC Hillman Cancer Center in welcoming Tatiana Moiseeva, PhD, effective February 1, 2024. She is an assistant professor in the Department of Pharmacology and Chemical Biology at the University of Pittsburgh and a member of the Genome Stability…
It is common practice for clinicians to administer granulocyte colony-stimulating factor (G-CSF) — a growth factor used to replenish white blood cell counts — during chemotherapy, but what are its effects on overall survival in patients with pancreatic cancer? …
As part of our strategic planning and our evolving plan to enhance diversity, we are realigning our leadership to better serve our community. We have consolidated our three population-based Associate Director (AD) roles into two: AD for Community Outreach and…
The 35th Annual UPMC Hillman Cancer Center Scientific Retreat was held September 26-27, 2023. The event consisted of lectures, including the Director’s Annual State of the Cancer Center, a shark tank-style minnow competition, and poster presentations. Featured Lectures Ronald B.…
After a national search and with approval of the External Advisory Board, UPMC Hillman Cancer Center is pleased to announce Jason J. Luke, MD, FACP, has been appointed the Associate Director (AD) of Clinical Research. Dr. Luke served as the…
